| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 140.85 | USD -3,521 | The ETF sold 25 shares of DVA on 2025-05-21. The shares were previously bought for an average price of USD 154.347. The DaVita HealthCare Partners Inc shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 337 The average price that the ETF previously sold DVA share for is USD 153.338 which is higher than the selling price of USD 140.85 on 2025-05-21. |
| CRL - Creightons Plc | SELL | -28 @ USD 134.98 | USD -3,779 | The ETF sold 28 shares of CRL on 2025-05-21. The shares were previously bought for an average price of USD 168.232. The Creightons Plc shares were sold for -19.8% lower than average price of previous purchases. This resulted in an overall loss of USD 931 The average price that the ETF previously sold CRL share for is USD 187.988 which is higher than the selling price of USD 134.98 on 2025-05-21. |
| TECH - Bio-Techne Corp | SELL | -87 @ USD 46.66 | USD -4,059 | The ETF sold 87 shares of TECH on 2025-05-21. The shares were previously bought for an average price of USD 65.0058. The Bio-Techne Corp shares were sold for -28.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,596 The average price that the ETF previously sold TECH share for is USD 70.2631 which is higher than the selling price of USD 46.66 on 2025-05-21. |
| MRNA - Moderna Inc | SELL | -184 @ USD 25.8 | USD -4,747 | The ETF sold 184 shares of MRNA on 2025-05-21. The shares were previously bought for an average price of USD 35.3915. The Moderna Inc shares were sold for -27.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,765 The average price that the ETF previously sold MRNA share for is USD 41.3652 which is higher than the selling price of USD 25.8 on 2025-05-21. |
| HSIC - Henry Schein Inc | SELL | -69 @ USD 72.08 | USD -4,974 | The ETF sold 69 shares of HSIC on 2025-05-21. The shares were previously bought for an average price of USD 72.8322. The Henry Schein Inc shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 52 The average price that the ETF previously sold HSIC share for is USD 71.1192 so the ETF has sold 69 shares on 2025-05-21 at a higher price than the previous selling average. |
| SOLV - Solventum Corp. | SELL | -74 @ USD 72.76 | USD -5,384 | The ETF sold 74 shares of SOLV on 2025-05-21. The shares were previously bought for an average price of USD 74.1474. The Solventum Corp. shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 103 The average price that the ETF previously sold SOLV share for is USD 70.3009 so the ETF has sold 74 shares on 2025-05-21 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -668 @ USD 8.48 | USD -5,665 | The ETF sold 668 shares of VTRS on 2025-05-21. The shares were previously bought for an average price of USD 10.3985. The Viatris Inc shares were sold for -18.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,282 The average price that the ETF previously sold VTRS share for is USD 12.086 which is higher than the selling price of USD 8.48 on 2025-05-21. |
| INCY - Incyte Corporation | SELL | -89 @ USD 64.78 | USD -5,765 | The ETF sold 89 shares of INCY on 2025-05-21. The shares were previously bought for an average price of USD 69.0067. The Incyte Corporation shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of USD 376 The average price that the ETF previously sold INCY share for is USD 72.3698 which is higher than the selling price of USD 64.78 on 2025-05-21. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 190.15 | USD -5,895 | The ETF sold 31 shares of UHS on 2025-05-21. The shares were previously bought for an average price of USD 189.072. The Universal Health Services Inc shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of USD 33 The average price that the ETF previously sold UHS share for is USD 192.71 which is higher than the selling price of USD 190.15 on 2025-05-21. |
| RVTY - Revvity Inc. | SELL | -68 @ USD 89.83 | USD -6,108 | The ETF sold 68 shares of RVTY on 2025-05-21. The shares were previously bought for an average price of USD 111.979. The Revvity Inc. shares were sold for -19.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,506 The average price that the ETF previously sold RVTY share for is USD 113.483 which is higher than the selling price of USD 89.83 on 2025-05-21. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 171.91 | USD -6,704 | The ETF sold 39 shares of ALGN on 2025-05-21. The shares were previously bought for an average price of USD 188.268. The Align Technology Inc shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 638 The average price that the ETF previously sold ALGN share for is USD 214.678 which is higher than the selling price of USD 171.91 on 2025-05-21. |
| HOLX - Hologic Inc | SELL | -124 @ USD 54.82 | USD -6,798 | The ETF sold 124 shares of HOLX on 2025-05-21. The shares were previously bought for an average price of USD 66.9002. The Hologic Inc shares were sold for -18.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,498 The average price that the ETF previously sold HOLX share for is USD 71.9605 which is higher than the selling price of USD 54.82 on 2025-05-21. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 208.95 | USD -8,149 | The ETF sold 39 shares of WST on 2025-05-21. The shares were previously bought for an average price of USD 256.3. The West Pharmaceutical Services Inc shares were sold for -18.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,847 The average price that the ETF previously sold WST share for is USD 302.729 which is higher than the selling price of USD 208.95 on 2025-05-21. |
| BAX - Baxter International Inc | SELL | -280 @ USD 30.43 | USD -8,520 | The ETF sold 280 shares of BAX on 2025-05-21. The shares were previously bought for an average price of USD 33.3208. The Baxter International Inc shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 809 The average price that the ETF previously sold BAX share for is USD 32.4067 which is higher than the selling price of USD 30.43 on 2025-05-21. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -112 @ USD 79.37 | USD -8,889 | The ETF sold 112 shares of COO on 2025-05-21. The shares were previously bought for an average price of USD 89.0886. The The Cooper Companies, Inc. Common Stock shares were sold for -10.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,088 The average price that the ETF previously sold COO share for is USD 95.7831 which is higher than the selling price of USD 79.37 on 2025-05-21. |
| MOH - MOH | SELL | -30 @ USD 319.62 | USD -9,589 | The ETF sold 30 shares of MOH on 2025-05-21. The shares were previously bought for an average price of USD 309.477. The MOH shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 304 The average price that the ETF previously sold MOH share for is USD 306.712 so the ETF has sold 30 shares on 2025-05-21 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 319.62 | USD -9,589 | The ETF sold 30 shares of MOH on 2025-05-21. The shares were previously bought for an average price of USD 309.477. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 304 The average price that the ETF previously sold MOH share for is USD 306.712 so the ETF has sold 30 shares on 2025-05-21 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -109 @ USD 92.74 | USD -10,109 | The ETF sold 109 shares of ZBH on 2025-05-21. The shares were previously bought for an average price of USD 107.101. The Zimmer Biomet Holdings Inc shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,565 The average price that the ETF previously sold ZBH share for is USD 107.13 which is higher than the selling price of USD 92.74 on 2025-05-21. |
| BIIB - Biogen Inc | SELL | -80 @ USD 126.82 | USD -10,146 | The ETF sold 80 shares of BIIB on 2025-05-21. The shares were previously bought for an average price of USD 145.643. The Biogen Inc shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,506 The average price that the ETF previously sold BIIB share for is USD 157.138 which is higher than the selling price of USD 126.82 on 2025-05-21. |
| DGX - Quest Diagnostics Incorporated | SELL | -62 @ USD 170.48 | USD -10,570 | The ETF sold 62 shares of DGX on 2025-05-21. The shares were previously bought for an average price of USD 167.015. The Quest Diagnostics Incorporated shares were sold for 2.1% higher than average price of previous purchases. This sale made a profit of USD 215 The average price that the ETF previously sold DGX share for is USD 159.85 so the ETF has sold 62 shares on 2025-05-21 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 241.34 | USD -10,860 | The ETF sold 45 shares of LH on 2025-05-21. The shares were previously bought for an average price of USD 241.284. The Laboratory Corporation of America Holdings shares were sold for 0.0% higher than average price of previous purchases. This sale made a profit of USD 3 The average price that the ETF previously sold LH share for is USD 236.234 so the ETF has sold 45 shares on 2025-05-21 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -32 @ USD 347.36 | USD -11,116 | The ETF sold 32 shares of WAT on 2025-05-21. The shares were previously bought for an average price of USD 369.261. The Waters Corporation shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of USD 701 The average price that the ETF previously sold WAT share for is USD 372.072 which is higher than the selling price of USD 347.36 on 2025-05-21. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 347.36 | USD -11,116 | The ETF sold 32 shares of WAT on 2025-05-21. The shares were previously bought for an average price of USD 369.261. The MULETFWATIMETFP shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of USD 701 The average price that the ETF previously sold WAT share for is USD 372.072 which is higher than the selling price of USD 347.36 on 2025-05-21. |
| PODD - Insulet Corporation | SELL | -38 @ USD 324.5 | USD -12,331 | The ETF sold 38 shares of PODD on 2025-05-21. The shares were previously bought for an average price of USD 268.184. The Insulet Corporation shares were sold for 21.0% higher than average price of previous purchases. This sale made a profit of USD 2,140 The average price that the ETF previously sold PODD share for is USD 263.826 so the ETF has sold 38 shares on 2025-05-21 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1133.26 | USD -12,466 | The ETF sold 11 shares of MTD on 2025-05-21. The shares were previously bought for an average price of USD 1239.38. The Mettler-Toledo International Inc shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,167 The average price that the ETF previously sold MTD share for is USD 1237.61 which is higher than the selling price of USD 1133.26 on 2025-05-21. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1133.26 | USD -12,466 | The ETF sold 11 shares of MTD on 2025-05-21. The shares were previously bought for an average price of USD 1239.38. The AMUNDI EUR GOV 710 shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,167 The average price that the ETF previously sold MTD share for is USD 1237.61 which is higher than the selling price of USD 1133.26 on 2025-05-21. |
| IQV - IQVIA Holdings Inc | SELL | -92 @ USD 137.29 | USD -12,631 | The ETF sold 92 shares of IQV on 2025-05-21. The shares were previously bought for an average price of USD 191.616. The IQVIA Holdings Inc shares were sold for -28.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,998 The average price that the ETF previously sold IQV share for is USD 196.377 which is higher than the selling price of USD 137.29 on 2025-05-21. |
| STE - STERIS plc | SELL | -54 @ USD 246.33 | USD -13,302 | The ETF sold 54 shares of STE on 2025-05-21. The shares were previously bought for an average price of USD 222.089. The STERIS plc shares were sold for 10.9% higher than average price of previous purchases. This sale made a profit of USD 1,309 The average price that the ETF previously sold STE share for is USD 215.915 so the ETF has sold 54 shares on 2025-05-21 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -66 @ USD 245.77 | USD -16,221 | The ETF sold 66 shares of HUM on 2025-05-21. The shares were previously bought for an average price of USD 270.038. The Hummingbird Resources PLC shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,602 The average price that the ETF previously sold HUM share for is USD 276.535 which is higher than the selling price of USD 245.77 on 2025-05-21. |
| HUM - Humana Inc | SELL | -66 @ USD 245.77 | USD -16,221 | The ETF sold 66 shares of HUM on 2025-05-21. The shares were previously bought for an average price of USD 270.038. The Humana Inc shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,602 The average price that the ETF previously sold HUM share for is USD 276.535 which is higher than the selling price of USD 245.77 on 2025-05-21. |
| CNC - Concurrent Technologies Plc | SELL | -276 @ USD 60.74 | USD -16,764 | The ETF sold 276 shares of CNC on 2025-05-21. The shares were previously bought for an average price of USD 60.1182. The Concurrent Technologies Plc shares were sold for 1.0% higher than average price of previous purchases. This sale made a profit of USD 172 The average price that the ETF previously sold CNC share for is USD 60.0808 so the ETF has sold 276 shares on 2025-05-21 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -157 @ USD 108.91 | USD -17,099 | The ETF sold 157 shares of A on 2025-05-21. The shares were previously bought for an average price of USD 128.911. The Agilent Technologies Inc shares were sold for -15.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,140 The average price that the ETF previously sold A share for is USD 132.187 which is higher than the selling price of USD 108.91 on 2025-05-21. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -251 @ USD 69.58 | USD -17,465 | The ETF sold 251 shares of GEHC on 2025-05-21. The shares were previously bought for an average price of USD 84.8343. The GE HealthCare Technologies Inc. shares were sold for -18.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,829 The average price that the ETF previously sold GEHC share for is USD 81.0542 which is higher than the selling price of USD 69.58 on 2025-05-21. |
| DXCM - DexCom Inc | SELL | -216 @ USD 84.89 | USD -18,336 | The ETF sold 216 shares of DXCM on 2025-05-21. The shares were previously bought for an average price of USD 77.8843. The DexCom Inc shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of USD 1,513 The average price that the ETF previously sold DXCM share for is USD 75.7744 so the ETF has sold 216 shares on 2025-05-21 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -81 @ USD 245.78 | USD -19,908 | The ETF sold 81 shares of RMD on 2025-05-21. The shares were previously bought for an average price of USD 234.22. The ResMed Inc shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of USD 936 The average price that the ETF previously sold RMD share for is USD 240.162 so the ETF has sold 81 shares on 2025-05-21 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -133 @ USD 153.31 | USD -20,390 | The ETF sold 133 shares of CAH on 2025-05-21. The shares were previously bought for an average price of USD 128.331. The Cardinal Health Inc shares were sold for 19.5% higher than average price of previous purchases. This sale made a profit of USD 3,322 The average price that the ETF previously sold CAH share for is USD 122.98 so the ETF has sold 133 shares on 2025-05-21 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 500.87 | USD -22,038 | The ETF sold 44 shares of IDXX on 2025-05-21. The shares were previously bought for an average price of USD 440.802. The IDEXX Laboratories Inc shares were sold for 13.6% higher than average price of previous purchases. This sale made a profit of USD 2,643 The average price that the ETF previously sold IDXX share for is USD 429.01 so the ETF has sold 44 shares on 2025-05-21 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -324 @ USD 76.1 | USD -24,656 | The ETF sold 324 shares of EW on 2025-05-21. The shares were previously bought for an average price of USD 71.2794. The Edwards Lifesciences Corp shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 1,562 The average price that the ETF previously sold EW share for is USD 70.4534 so the ETF has sold 324 shares on 2025-05-21 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -157 @ USD 173.14 | USD -27,183 | The ETF sold 157 shares of BDX on 2025-05-21. The shares were previously bought for an average price of USD 226.588. The Becton Dickinson and Company shares were sold for -23.6% lower than average price of previous purchases. This resulted in an overall loss of USD 8,391 The average price that the ETF previously sold BDX share for is USD 222.815 which is higher than the selling price of USD 173.14 on 2025-05-21. |
| COR - Cencora Inc. | SELL | -94 @ USD 291.36 | USD -27,388 | The ETF sold 94 shares of COR on 2025-05-21. The shares were previously bought for an average price of USD 254.646. The Cencora Inc. shares were sold for 14.4% higher than average price of previous purchases. This sale made a profit of USD 3,451 The average price that the ETF previously sold COR share for is USD 246.92 so the ETF has sold 94 shares on 2025-05-21 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -57 @ USD 604.62 | USD -34,463 | The ETF sold 57 shares of REGN on 2025-05-21. The shares were previously bought for an average price of USD 704.506. The Regeneron Pharmaceuticals Inc shares were sold for -14.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,694 The average price that the ETF previously sold REGN share for is USD 746.495 which is higher than the selling price of USD 604.62 on 2025-05-21. |
| HCA - HCA Holdings Inc | SELL | -97 @ USD 381.81 | USD -37,036 | The ETF sold 97 shares of HCA on 2025-05-21. The shares were previously bought for an average price of USD 337.989. The HCA Holdings Inc shares were sold for 13.0% higher than average price of previous purchases. This sale made a profit of USD 4,251 The average price that the ETF previously sold HCA share for is USD 327.991 so the ETF has sold 97 shares on 2025-05-21 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -244 @ USD 161.44 | USD -39,391 | The ETF sold 244 shares of ZTS on 2025-05-21. The shares were previously bought for an average price of USD 167.219. The Zoetis Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,410 The average price that the ETF previously sold ZTS share for is USD 171.425 which is higher than the selling price of USD 161.44 on 2025-05-21. |
| CVS - CVS Health Corp | SELL | -688 @ USD 62.11 | USD -42,732 | The ETF sold 688 shares of CVS on 2025-05-21. The shares were previously bought for an average price of USD 62.9223. The CVS Health Corp shares were sold for -1.3% lower than average price of previous purchases. This resulted in an overall loss of USD 559 The average price that the ETF previously sold CVS share for is USD 55.4798 so the ETF has sold 688 shares on 2025-05-21 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -149 @ USD 317.09 | USD -47,246 | The ETF sold 149 shares of CI on 2025-05-21. The shares were previously bought for an average price of USD 316.767. The Cigna Corp shares were sold for 0.1% higher than average price of previous purchases. This sale made a profit of USD 48 The average price that the ETF previously sold CI share for is USD 312.862 so the ETF has sold 149 shares on 2025-05-21 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -68 @ USD 718.73 | USD -48,874 | The ETF sold 68 shares of MCK on 2025-05-21. The shares were previously bought for an average price of USD 621.578. The McKesson Corporation shares were sold for 15.6% higher than average price of previous purchases. This sale made a profit of USD 6,606 The average price that the ETF previously sold MCK share for is USD 603.921 so the ETF has sold 68 shares on 2025-05-21 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -126 @ USD 400.12 | USD -50,415 | The ETF sold 126 shares of ELV on 2025-05-21. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,339 The average price that the ETF previously sold ELV share for is USD 401.899 which is higher than the selling price of USD 400.12 on 2025-05-21. |
| ELV - Elevance Health Inc | SELL | -126 @ USD 400.12 | USD -50,415 | The ETF sold 126 shares of ELV on 2025-05-21. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,339 The average price that the ETF previously sold ELV share for is USD 401.899 which is higher than the selling price of USD 400.12 on 2025-05-21. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,107 @ USD 47 | USD -52,029 | The ETF sold 1107 shares of BMY on 2025-05-21. The shares were previously bought for an average price of USD 57.3147. The Bloomsbury Publishing Plc shares were sold for -18.0% lower than average price of previous purchases. This resulted in an overall loss of USD 11,418 The average price that the ETF previously sold BMY share for is USD 56.3156 which is higher than the selling price of USD 47 on 2025-05-21. |
| MDT - Medtronic PLC | SELL | -699 @ USD 84.41 | USD -59,003 | The ETF sold 699 shares of MDT on 2025-05-21. The shares were previously bought for an average price of USD 88.7467. The Medtronic PLC shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,031 The average price that the ETF previously sold MDT share for is USD 85.3937 which is higher than the selling price of USD 84.41 on 2025-05-21. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -139 @ USD 435.32 | USD -60,509 | The ETF sold 139 shares of VRTX on 2025-05-21. The shares were previously bought for an average price of USD 478.652. The Vertex Pharmaceuticals Inc shares were sold for -9.1% lower than average price of previous purchases. This resulted in an overall loss of USD 6,023 The average price that the ETF previously sold VRTX share for is USD 463.339 which is higher than the selling price of USD 435.32 on 2025-05-21. |
| DHR - Danaher Corporation | SELL | -348 @ USD 186.81 | USD -65,010 | The ETF sold 348 shares of DHR on 2025-05-21. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of USD 10,395 The average price that the ETF previously sold DHR share for is USD 230.708 which is higher than the selling price of USD 186.81 on 2025-05-21. |
| DHR - Danaher Corporation | SELL | -348 @ USD 186.81 | USD -65,010 | The ETF sold 348 shares of DHR on 2025-05-21. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of USD 10,395 The average price that the ETF previously sold DHR share for is USD 230.708 which is higher than the selling price of USD 186.81 on 2025-05-21. |
| SYK - Stryker Corporation | SELL | -187 @ USD 379.75 | USD -71,013 | The ETF sold 187 shares of SYK on 2025-05-21. The shares were previously bought for an average price of USD 379.729. The Stryker Corporation shares were sold for 0.0% higher than average price of previous purchases. This sale made a profit of USD 4 The average price that the ETF previously sold SYK share for is USD 375.139 so the ETF has sold 187 shares on 2025-05-21 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -3,085 @ USD 23.04 | USD -71,078 | The ETF sold 3085 shares of PFE on 2025-05-21. The shares were previously bought for an average price of USD 25.8066. The Pfizer Inc shares were sold for -10.7% lower than average price of previous purchases. This resulted in an overall loss of USD 8,535 The average price that the ETF previously sold PFE share for is USD 25.8815 which is higher than the selling price of USD 23.04 on 2025-05-21. |
| GILD - Guild Esports Plc | SELL | -678 @ USD 107.72 | USD -73,034 | The ETF sold 678 shares of GILD on 2025-05-21. The shares were previously bought for an average price of USD 102.991. The Guild Esports Plc shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of USD 3,206 The average price that the ETF previously sold GILD share for is USD 94.6031 so the ETF has sold 678 shares on 2025-05-21 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -292 @ USD 271.34 | USD -79,231 | The ETF sold 292 shares of AMGN on 2025-05-21. The shares were previously bought for an average price of USD 303.22. The Amgen Inc shares were sold for -10.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,309 The average price that the ETF previously sold AMGN share for is USD 288.898 which is higher than the selling price of USD 271.34 on 2025-05-21. |
| TMO - Time Out Group plc | SELL | -208 @ USD 398.28 | USD -82,842 | The ETF sold 208 shares of TMO on 2025-05-21. The shares were previously bought for an average price of USD 521.751. The Time Out Group plc shares were sold for -23.7% lower than average price of previous purchases. This resulted in an overall loss of USD 25,682 The average price that the ETF previously sold TMO share for is USD 519.917 which is higher than the selling price of USD 398.28 on 2025-05-21. |
| BSX - Boston Scientific Corporation | SELL | -802 @ USD 104.64 | USD -83,921 | The ETF sold 802 shares of BSX on 2025-05-21. The shares were previously bought for an average price of USD 98.6851. The Boston Scientific Corporation shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 4,776 The average price that the ETF previously sold BSX share for is USD 90.7685 so the ETF has sold 802 shares on 2025-05-21 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -802 @ USD 104.64 | USD -83,921 | The ETF sold 802 shares of BSX on 2025-05-21. The shares were previously bought for an average price of USD 98.6851. The MULSTRXSSXIMETFP shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 4,776 The average price that the ETF previously sold BSX share for is USD 90.7685 so the ETF has sold 802 shares on 2025-05-21 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -193 @ USD 547.07 | USD -105,585 | The ETF sold 193 shares of ISRG on 2025-05-21. The shares were previously bought for an average price of USD 541.1. The Intuitive Surgical Inc shares were sold for 1.1% higher than average price of previous purchases. This sale made a profit of USD 1,152 The average price that the ETF previously sold ISRG share for is USD 531.238 so the ETF has sold 193 shares on 2025-05-21 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -1,375 @ USD 76.98 | USD -105,848 | The ETF sold 1375 shares of MRK on 2025-05-21. The shares were previously bought for an average price of USD 91.8712. The Marks Electrical Group PLC shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 20,475 The average price that the ETF previously sold MRK share for is USD 98.2014 which is higher than the selling price of USD 76.98 on 2025-05-21. |
| MRK - Merck & Company Inc | SELL | -1,375 @ USD 76.98 | USD -105,848 | The ETF sold 1375 shares of MRK on 2025-05-21. The shares were previously bought for an average price of USD 91.8712. The Merck & Company Inc shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 20,475 The average price that the ETF previously sold MRK share for is USD 98.2014 which is higher than the selling price of USD 76.98 on 2025-05-21. |
| ABT - Abbott Laboratories | SELL | -942 @ USD 133.05 | USD -125,333 | The ETF sold 942 shares of ABT on 2025-05-21. The shares were previously bought for an average price of USD 127.034. The Abbott Laboratories shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 5,667 The average price that the ETF previously sold ABT share for is USD 118.058 so the ETF has sold 942 shares on 2025-05-21 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -500 @ USD 302.98 | USD -151,490 | The ETF sold 500 shares of UNH on 2025-05-21. The shares were previously bought for an average price of USD 524.136. The UnitedHealth Group Incorporated shares were sold for -42.2% lower than average price of previous purchases. This resulted in an overall loss of USD 110,578 The average price that the ETF previously sold UNH share for is USD 552.054 which is higher than the selling price of USD 302.98 on 2025-05-21. |
| ABBV - AbbVie Inc | SELL | -958 @ USD 181.8 | USD -174,164 | The ETF sold 958 shares of ABBV on 2025-05-21. The shares were previously bought for an average price of USD 193.556. The AbbVie Inc shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of USD 11,262 The average price that the ETF previously sold ABBV share for is USD 185.052 which is higher than the selling price of USD 181.8 on 2025-05-21. |
| JNJ - Johnson & Johnson | SELL | -1,307 @ USD 153.18 | USD -200,206 | The ETF sold 1307 shares of JNJ on 2025-05-21. The shares were previously bought for an average price of USD 157.979. The Johnson & Johnson shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 6,272 The average price that the ETF previously sold JNJ share for is USD 152.575 so the ETF has sold 1307 shares on 2025-05-21 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -427 @ USD 724.95 | USD -309,554 | The ETF sold 427 shares of LLY on 2025-05-21. The shares were previously bought for an average price of USD 837.646. The Eli Lilly and Company shares were sold for -13.5% lower than average price of previous purchases. This resulted in an overall loss of USD 48,121 The average price that the ETF previously sold LLY share for is USD 793.557 which is higher than the selling price of USD 724.95 on 2025-05-21. |